BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1610962)

  • 1. Interaction of thrombin with synthetic fluorescent substrate immobilized on polymer membrane.
    Ito Y; Liu LS; Imanishi Y
    Biomaterials; 1992; 13(6):375-81. PubMed ID: 1610962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro non-thrombogenicity of a thrombin-substrate-immobilized polymer surface by the inhibition of thrombin activity.
    Ito Y; Liu LS; Imanishi Y
    J Biomater Sci Polym Ed; 1991; 2(2):123-38. PubMed ID: 2054331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition.
    Charef S; Tapon-Bretaudière J; Fischer AM; Pflüger F; Jozefowicz M; Labarre D
    Biomaterials; 1996 May; 17(9):903-12. PubMed ID: 8718936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled preparation of thin fibrin films immobilized at solid surfaces.
    Riedel T; Brynda E; Dyr JE; Houska M
    J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilization of human thrombomodulin onto biomaterials. Comparison of immobilization methods and evaluation of antithrombogenicity.
    Kishida A; Ueno Y; Maruyama I; Akashi M
    ASAIO J; 1994; 40(3):M840-5. PubMed ID: 8555632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of hydrolysis of peptide thioester derivatives of arginine by human and bovine thrombins.
    Cook RR; McRae BJ; Powers JC
    Arch Biochem Biophys; 1984 Oct; 234(1):82-8. PubMed ID: 6486828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hydrolysis of methyl esters of N alpha-arylsulfonyl-arginine and N-arylsulfonyl-valyl-arginine by alpha- and beta/gamma-thrombins].
    Strukova SM; Semenova OA; Kireeva EG; Sereĭskaia AA; Romanova VP
    Biokhimiia; 1982 Apr; 47(4):528-33. PubMed ID: 7082687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most clot-bound thrombin activity is inhibited by plasma antithrombin during clot aging, but a very small fraction survives.
    Komatsu Y; Hayashi H
    Biol Pharm Bull; 2000 Apr; 23(4):502-5. PubMed ID: 10784436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of thrombin with fibrinogen adsorbed on methyl-, hydroxyl-, amine-, and carboxyl-terminated self-assembled monolayers.
    Evans-Nguyen KM; Tolles LR; Gorkun OV; Lord ST; Schoenfisch MH
    Biochemistry; 2005 Nov; 44(47):15561-8. PubMed ID: 16300405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.
    Keuren JF; Wielders SJ; Willems GM; Morra M; Lindhout T
    Thromb Haemost; 2002 Apr; 87(4):742-7. PubMed ID: 12008960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on a new strategy for surface modification of polymeric biomaterials.
    Aldenhoff YB; Koole LH
    J Biomed Mater Res; 1995 Aug; 29(8):917-28. PubMed ID: 7593035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of enhanced thromboresistance of polymeric materials in the presence of heparin.
    Platé NA; Valuev LI
    Biomaterials; 1983 Jan; 4(1):14-20. PubMed ID: 6838953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemocompatibility of polyacrylonitrile dialysis membrane immobilized with chitosan and heparin conjugate.
    Lin WC; Liu TY; Yang MC
    Biomaterials; 2004 May; 25(10):1947-57. PubMed ID: 14738859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibited thrombins. Interactions with fibrinogen and fibrin.
    Kaminski M; McDonagh J
    Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protons on the thrombin-fibrinogen interaction.
    Picozzi M; Landolfi R; De Cristofaro R
    Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New donor-acceptor pairs for fluorogenic substrates with intramolecular fluorescence energy transfer for thrombin and trypsin].
    Kholodovich VV; Kara DI; Gershkovich AA; Kibirev VK; Karabut LV; Klimenko IV; Korneliuk AI
    Bioorg Khim; 1998 Mar; 24(3):179-85. PubMed ID: 9612559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-thrombogenicity by novel surface modification methods.
    Ito Y; Imanishi Y
    J Biomater Appl; 1992 Apr; 6(4):293-318. PubMed ID: 1588484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioengineered surfaces to improve the blood compatibility of biomaterials through direct thrombin inactivation.
    Freitas SC; Cereija TB; Figueiredo AC; Osório H; Pereira PJ; Barbosa MA; Martins MC
    Acta Biomater; 2012 Nov; 8(11):4101-10. PubMed ID: 22846590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.